Genocea Biosciences, Inc.
GNCADelisted Jun 2, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001457612
Genocea Biosciences, Inc. was delisted on Jun 2, 2022; its insiders filed their last Form 4 on Jun 3, 2022; 40 institutions reported holding it in 13F filings for Q1 2022, worth $42.1M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Genocea Biosciences, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −6 vs. Q2 2021
- Shares held
- 34.0M
- +87.9K (+0.3%) vs. Q2 2021
- Total value
- $65.3M
- −$14.1M (−17.7%) vs. Q2 2021
- New holders
- 2
- 12 more added
- Sold out
- 8
- 8 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GNCA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $1 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $1 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 1 | $4.00K |
| Q2 2022 | 5 | $92.0K |
| Q1 2022 | 40 | $42.1M |
| Q4 2021 | 41 | $38.9M |
| Q3 2021 | 40 | $65.3M |
| Q2 2021 | 46 | $79.4M |
| Q1 2021 | 42 | $86.3M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Genocea Biosciences, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cutler Group LP | 900 | $1.00K | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 625 | $1.00K | 0.00% | +625 | New |
| Artemis Wealth Advisors, LLC | 1,137 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 800 | $2.00K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 1,037 | $2.00K | 0.00% | +1,037 | New |
| First Manhattan Co | 2,500 | $4.00K | 0.00% | 00.0% | Unchanged |
| ACT Capital Management, LLC | 5,000 | $10.0K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,902 | $11.0K | 0.00% | −2,672−31.2% | Reduced |
| Vectors Research Management, LLC | 6,000 | $12.0K | 0.00% | +1,000+20.0% | Added |
| Wells Fargo & Company | 9,668 | $18.0K | 0.00% | +136+1.4% | Added |
| Capital Asset Advisory Services LLC | 11,766 | $23.0K | 0.00% | 00.0% | Unchanged |
| First Republic Investment Management, Inc. | 12,285 | $24.0K | 0.00% | 00.0% | Unchanged |
| WealthTrust Axiom LLC | 15,000 | $28.0K | 0.01% | 00.0% | Unchanged |
| Personal Capital Advisors Corp | 15,000 | $29.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 15,669 | $30.0K | 0.00% | −835−5.1% | Reduced |
| Bank of New York Mellon Corp | 16,305 | $31.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 19,916 | $38.0K | 0.00% | −3,179−13.8% | Reduced |
| State Street Corp | 19,684 | $38.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 21,405 | $41.0K | 0.00% | +700+3.4% | Added |
| Northern Trust Corp | 56,469 | $108.0K | 0.00% | +16,587+41.6% | Added |
| Bank of America Corp | 57,363 | $110.0K | 0.00% | +177+0.3% | Added |
| Two Sigma Investments, LP | 57,836 | $111.0K | 0.00% | −96,611−62.6% | Reduced |
| Group One Trading, L.P. | 61,614 | $118.0K | 0.00% | +41,939+213.2% | Added |
| Two Sigma Advisers, LP | 142,477 | $274.0K | 0.00% | −106,000−42.7% | Reduced |
| BlackRock Inc. | 180,991 | $347.0K | 0.00% | +2,019+1.1% | Added |
| Geode Capital Management, LLC | 185,942 | $357.0K | 0.00% | +6,228+3.5% | Added |
| Ikarian Capital, LLC | 196,821 | $377.0K | 0.09% | −3,179−1.6% | Reduced |
| Polaris Venture Management Co. V, L.L.C. | 197,345 | $379.0K | 2.69% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 212,260 | $408.0K | 0.00% | −100.0% | Reduced |
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $720.0K | 29.91% | 00.0% | Unchanged |
| Millennium Management LLC | 377,345 | $725.0K | 0.00% | +91,304+31.9% | Added |
| Boxer Capital, LLC | 1,134,453 | $2.18M | 0.08% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,563,101 | $3.00M | 0.00% | +24,638+1.6% | Added |
| Citadel Advisors LLC | 1,853,826 | $3.56M | 0.00% | −18,410−1.0% | Reduced |
| Kingdon Capital Management, L.L.C. | 1,972,056 | $3.79M | 0.66% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 2,652,974 | $5.09M | 0.02% | +152,974+6.1% | Added |
| Commodore Capital LP | 3,079,756 | $5.91M | 1.56% | +150,309+5.1% | Added |
| BVF Inc | 4,012,404 | $7.70M | 0.30% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 5,084,184 | $9.76M | 0.15% | 00.0% | Unchanged |
| NEA Management Company, LLC | 10,376,936 | $19.9M | 0.25% | 00.0% | Unchanged |
| Diametric Capital, LP | 0 | $0 | 0.00% | −69,977−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −43,643−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −19,170−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,625−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −11,131−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −7,200−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,834−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −250−100.0% | Sold out |